Homologous recombination and its regulation
Open accessThe DOI matches its Crossref record; 312 of the 312 references it cites were found in a registry or an index.
Abstract
Homologous recombination (HR) is critical both for repairing DNA lesions in mitosis and for chromosomal pairing and exchange during meiosis. However, some forms of HR can also lead to undesirable DNA rearrangements. Multiple regulatory mechanisms have evolved to ensure that HR takes place at the right time, place and manner. Several of these impinge on the control of Rad51 nucleofilaments that play a central role in HR. Some factors promote the formation of these structures while others lead to their disassembly or the use of alternative repair pathways. In this article, we review these mechanisms in both mitotic and meiotic environments and in different eukaryotic taxa, with an emphasis on yeast and mammal systems. Since mutations in several proteins that regulate Rad51 nucleofilaments are associated with cancer and cancer-prone syndromes, we discuss how understanding their functions can lead to the development of better tools for cancer diagnosis and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683 · cited 2×
“One main concept in devising these strategies is that HR-deficient tumours are more sensitive to killing by DNA damaging agents or by chemicals that inhibit other repair pathways or checkpoint mechanisms (208,307,308).”
BackgroundThe DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092 · cited 1×
“It has been estimated that more than tens of thousands of DNA lesions occur in a single human cell every day (1).”
BackgroundSpecific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
ATM and ATR Substrate Analysis Reveals Extensive Protein Networks Responsive to DNA Damage
Matsuoka, S., Ballif, B. A., Smogorzewska, A., McDonald, E. R., Hurov, K. E., Luo, J., Bakalarski, C. E., Zhao, Z., Solimini, N., Lerenthal, Y., et al. (2007) · Science · doi:10.1126/science.1140321 · Cited by 3,075
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693 · cited 1×
“Phosphorylation of RPA by these kinases is critical for Rad51 recruitment to DSB sites or for HR during replication stress (30,123).”
BackgroundThe double-strand-break repair model for recombination
Szostak, J. W., Orr-Weaver, T. L., Rothstein, R. J., & Stahl, F. W. (1983) · Cell · doi:10.1016/0092-8674(83)90331-8 · Cited by 2,437
Multiple Pathways of Recombination Induced by Double-Strand Breaks in Saccharomyces cerevisiae
Pâques, F., & Haber, J. E. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.2.349-404.1999 · Cited by 2,120
An Oncogene-Induced DNA Damage Model for Cancer Development
Halazonetis, T. D., Gorgoulis, V. G., & Bartek, J. (2008) · Science · doi:10.1126/science.1140735 · Cited by 1,851
Mechanism of Eukaryotic Homologous Recombination
San Filippo, J., Sung, P., & Klein, H. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061306.125255 · Cited by 1,681
The Concept of Synthetic Lethality in the Context of Anticancer Therapy
Kaelin, W. G. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1691 · Cited by 1,379
Cited by
Therapeutic genome editing: prospects and challenges
Cox, D. B. T., Platt, R. J., & Zhang, F. (2015) · Nature Medicine · doi:10.1038/nm.3793 · Cited by 1,336
Exploring and comparing adverse events between PARP inhibitors
LaFargue, C. J., Dal Molin, G. Z., Sood, A. K., & Coleman, R. L. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30786-1 · Cited by 487
Maréchal, A., & Zou, L. (2015) · Cell Research · doi:10.1038/cr.2014.147 · Cited by 465
Inflammation-induced DNA damage, mutations and cancer
Kay, J., Thadhani, E., Samson, L., & Engelward, B. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.102673 · Cited by 464
The linear quadratic model: usage, interpretation and challenges
McMahon, S. J. (2018) · Physics in Medicine & Biology · doi:10.1088/1361-6560/aaf26a · Cited by 440
DNA damage foci: Meaning and significance
Rothkamm, K., Barnard, S., Moquet, J., Ellender, M., Rana, Z., & Burdak‐Rothkamm, S. (2015) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21944 · Cited by 335
Ionizing radiation-induced DNA injury and damage detection in patients with breast cancer
Borrego-Soto, G., Ortiz-López, R., & Rojas-Martínez, A. (2015) · Genetics and Molecular Biology · doi:10.1590/s1415-475738420150019 · Cited by 320
Faino, L., Seidl, M. F., Shi-Kunne, X., Pauper, M., van den Berg, G. C. M., Wittenberg, A. H. J., & Thomma, B. P. H. J. (2016) · Genome Research · doi:10.1101/gr.204974.116 · Cited by 319
Paleček, E., Tkáč, J., Bartošík, M., Bertók, T., Ostatná, V., & Paleček, J. (2015) · Chemical Reviews · doi:10.1021/cr500279h · Cited by 319
Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches
Dietlein, F., Thelen, L., & Reinhardt, H. C. (2014) · Trends in Genetics · doi:10.1016/j.tig.2014.06.003 · Cited by 280
The Ku heterodimer: Function in DNA repair and beyond
Fell, V. L., & Schild-Poulter, C. (2015) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2014.06.002 · Cited by 273
BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance
Gorodetska, I., Kozeretska, I., & Dubrovska, A. (2019) · Journal of Cancer · doi:10.7150/jca.30410 · Cited by 269
The current state of molecular testing in the treatment of patients with solid tumors, 2019
El‐Deiry, W. S., Goldberg, R. M., Lenz, H., Shields, A. F., Gibney, G. T., Tan, A. R., Brown, J., Eisenberg, B., Heath, E. I., Phuphanich, S., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21560 · Cited by 264
Chen, R., & Wold, M. S. (2014) · BioEssays · doi:10.1002/bies.201400107 · Cited by 259
Molecular mechanisms of activity and derepression of alternative lengthening of telomeres
Pickett, H. A., & Reddel, R. R. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3106 · Cited by 203
Delivery of CRISPR/Cas9 for therapeutic genome editing
Xu, X., Wan, T., Xin, H., Li, D., Pan, H., Wu, J., & Ping, Y. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3107 · Cited by 134
BRCA1 and S phase DNA repair pathways restrict LINE-1 retrotransposition in human cells
Mita, P., Sun, X., Fenyö, D., Kahler, D. J., Li, D., Agmon, N., Wudzinska, A., Keegan, S., Bader, J. S., Yun, C., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0374-z · Cited by 113
Cellular senescence and tumor promotion: Is aging the key?
Loaiza, N., & Demaria, M. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2016.01.007 · Cited by 101
Fedor, Y., Vignard, J., Nicolau-Travers, M.-L., Boutet-Robinet, E., Watrin, C., Salles, B., & Mirey, G. (2013) · Cellular Microbiology · doi:10.1111/cmi.12028 · Cited by 90
“Indeed, during HR process, RPA has to be displaced from ssDNA by recombination mediators, to allow RAD51 nucleofilament formation (reviewed in Krejci et al. (2012).”
BackgroundTwo Mechanisms Produce Mutation Hotspots at DNA Breaks in Escherichia coli
Shee, C., Gibson, J. L., & Rosenberg, S. M. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.08.033 · Cited by 68
“Mice and humans possess homologs and analogs of bacterial HR-DSBrepair proteins (Krejci et al., 2012), and three homologs and an ortholog of DinB (Nohmi, 2006); therefore, it is plausible that mouse and human mutation showers (Nik-Zainal et al.”
BackgroundTargeting DNA damage repair pathways in pancreas cancer
Crowley, F., Park, W., & O’Reilly, E. M. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09983-1 · Cited by 43
Miao, W., XuFeng, R., Park, M.-R., Gu, H., Hu, L., Kang, J. W., Ma, S., Liang, P. H., Li, Y., Cheng, H., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.232 · Cited by 37
Kumar, N., Taneja, A., Ghosh, M., Rothweiler, U., Sundaresan, N. R., & Singh, M. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkad1208 · Cited by 12
FIRRM and FIGNL1: partners in the regulation of homologous recombination
Tsaridou, S., & van Vugt, M. A. T. M. (2024) · Trends in Genetics · doi:10.1016/j.tig.2024.02.007 · Cited by 8
Metadata
- Authors
- Krejci, L., Altmannova, V., Spirek, M., & Zhao, X.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-03-30
- Volume
- 40
- Issue
- 13
- Pages
- 5795-5818
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2126404651
- Cited by
- 641
- References
- 312
- FWCI
- 19.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.